HLA-DQB1, major histocompatibility complex, class II, DQ beta 1, 3119
N. diseases: 504; N. variants: 43
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 6 | 32661978 | missense variant | G/A;T | snv | 0.20 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
6 | 32667852 | intron variant | G/A | snv |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||||
|
6 | 32660761 | intron variant | GG/- | del |
|
0.700 | 1.000 | 1 | 2015 | 2015 | |||||||||||
|
1.000 | 0.080 | 6 | 32665110 | intron variant | C/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.120 | 6 | 32668286 | 5 prime UTR variant | -/CA | delins |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
6 | 32665113 | intron variant | C/A;G | snv | 1.5E-05 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
6 | 32660307 | intron variant | C/T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Stomatognathic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
Neoplasms; Respiratory Tract Diseases; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.160 | 6 | 32668343 | 5 prime UTR variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
1.000 | 0.040 | 6 | 32664881 | missense variant | A/T | snv | 3.2E-05 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
6 | 32664039 | non coding transcript exon variant | T/A;G | snv |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||||
|
6 | 32659175 | upstream gene variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
1.000 | 0.040 | 6 | 32667519 | intron variant | C/T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
6 | 32661035 | intron variant | C/A;T | snv |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.120 | 6 | 32661407 | missense variant | A/G | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2000 | 2000 |